
Dr Venexia Walker
MMath, PhD
Current positions
Senior Lecturer
Epidemiology and Health Data Science
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
I specialise in causal inference, with particular expertise in target trial emulation and Mendelian randomization. My research spans several clinical areas, including cardiovascular, renal and neurodegenerative disease, with a focus on using large-scale genetic and electronic health record data to generate robust evidence for disease prevention and treatment. I am co-lead of the Electronic Health Records Group and linked faculty at the MRC Integrative Epidemiology Unit, contributing to programmes on Mendelian Randomization and Data Mining Epidemiological Relationships.
Projects and supervisions
Research projects
Identifying precision prevention strategies for obesity related cancers through enhanced understanding of biological mechanisms and risk prediction: the Obesity-related Cancer Epidemiology Programme (OCEP)
Principal Investigator
Role
Co-Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/02/2026 to 31/01/2031
Thesis supervisions
Application of Mendelian Randomization to Investigate Causal Relationship with Chronic Kidney Disease
Supervisors
A pharmacoepidemiological study of the risks and benefits to mothers and offspring of prescribing drugs during pregnancy
Supervisors
Leveraging large-scale molecular datasets to dissect immune-mediated pathways to disease and guide therapeutic opportunities
Supervisors
Publications
Selected publications
01/12/2017Mendelian randomization: A novel approach for the prediction of adverse drug events and drug repurposing opportunities
International Journal of Epidemiology
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Nature Genetics
Recent publications
07/09/2026The relationship between general practice characteristics, case-mix, and secondary care attendances/admissions before and after the COVID-19 lockdowns: SSM Annual Scientific Meeting
Antihypertensive Treatment and Risk of Metabolic Associated Fatty Liver Disease: A Drug-Target Mendelian Randomization
Hypertension
Effectiveness of bivalent BA.1 mRNA booster vaccines during the autumn 2022 COVID-19 booster programme in adults aged 50+ in England: observational matched cohort study using OpenSAFELY
Vaccine
Thesis
New uses for old drugs
Supervisors
Award date
13/09/2019



